Pharma & Healthcare Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027 Summary Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of pro...

$10,995.00 26 September, 2019 | GlobalData

B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027 Summary Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous gr...

Pharma & Healthcare

Spinal Muscular Atrophy (SMA): Opportunity Analysis and Forecasts to 2028

Spinal Muscular Atrophy (SMA): Opportunity Analysis and Forecasts to 2028 Summary SMA is an area that is expected to witness strong growth in the future, p...

$10,995.00 26 September, 2019 | GlobalData

Spinal Muscular Atrophy (SMA): Opportunity Analysis and Forecasts to 2028 Summary SMA is an area that is expected to witness strong growth in the...

Pharma & Healthcare

Respiratory Syncytial Virus: Epidemiology Forecast to 2028

Respiratory Syncytial Virus: Epidemiology Forecast to 2028 Summary Respiratory syncytial virus (RSV) is a common respiratory infection that most children w...

$3,995.00 26 September, 2019 | GlobalData

Respiratory Syncytial Virus: Epidemiology Forecast to 2028

$3,995.00 | 26 September, 2019 | GlobalData

Respiratory Syncytial Virus: Epidemiology Forecast to 2028 Summary Respiratory syncytial virus (RSV) is a common respiratory infection that most ...

Pharma & Healthcare

Ovarian Cancer: Epidemiology Forecast to 2028

Ovarian Cancer: Epidemiology Forecast to 2028 Summary Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence ...

$3,995.00 26 September, 2019 | GlobalData

Ovarian Cancer: Epidemiology Forecast to 2028

$3,995.00 | 26 September, 2019 | GlobalData

Ovarian Cancer: Epidemiology Forecast to 2028 Summary Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer ...

Pharma & Healthcare

Alopecia Areata: Epidemiology Forecast to 2028

Alopecia Areata: Epidemiology Forecast to 2028 Summary Alopecia areata (AA) is a common, clinically heterogeneous, immune-mediated and a non-scarring hair ...

$3,995.00 26 September, 2019 | GlobalData

Alopecia Areata: Epidemiology Forecast to 2028

$3,995.00 | 26 September, 2019 | GlobalData

Alopecia Areata: Epidemiology Forecast to 2028 Summary Alopecia areata (AA) is a common, clinically heterogeneous, immune-mediated and a non-scar...

Pharma & Healthcare

Spinal Muscular Atrophy: Epidemiology Forecast in Asia-Pacific Markets to 2028

Spinal Muscular Atrophy: Epidemiology Forecast in Asia-Pacific Markets to 2028 Summary Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscula...

$3,495.00 26 September, 2019 | GlobalData

Spinal Muscular Atrophy: Epidemiology Forecast in Asia-Pacific Markets to 2028 Summary Spinal muscular atrophy (SMA) is an autosomal recessive ne...

Pharma & Healthcare

PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition

PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition Summary This report characterizes the contract small molecul...

$4,995.00 26 September, 2019 | GlobalData

PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition Summary This report characterizes the contract sma...

Pharma & Healthcare

Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, Status and Forecast 2019-2025

This report focuses on the global Phosphodiesterase Type 5 (PDE5) Inhibitor status, future forecast, growth opportunity, key market and key players. The stud...

$3,900.00 26 September, 2019 | QYResearch

This report focuses on the global Phosphodiesterase Type 5 (PDE5) Inhibitor status, future forecast, growth opportunity, key market and key players...

Pharma & Healthcare

Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2019-2025

This report focuses on the global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players. The study o...

$3,900.00 26 September, 2019 | QYResearch

This report focuses on the global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players. T...

Pharma & Healthcare

Global Ergothioneine (EGT) Market Size, Status and Forecast 2019-2025

This report focuses on the global Ergothioneine (EGT) status, future forecast, growth opportunity, key market and key players. The study objectives are to pr...

$3,900.00 26 September, 2019 | QYResearch

This report focuses on the global Ergothioneine (EGT) status, future forecast, growth opportunity, key market and key players. The study objectives...